Allan N. Maroli

1.6k total citations · 1 hit paper
25 papers, 1.2k citations indexed

About

Allan N. Maroli is a scholar working on Pharmacology, Epidemiology and Nephrology. According to data from OpenAlex, Allan N. Maroli has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Epidemiology and 5 papers in Nephrology. Recurrent topics in Allan N. Maroli's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Pneumonia and Respiratory Infections (5 papers) and Gout, Hyperuricemia, Uric Acid (5 papers). Allan N. Maroli is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Pneumonia and Respiratory Infections (5 papers) and Gout, Hyperuricemia, Uric Acid (5 papers). Allan N. Maroli collaborates with scholars based in United States, United Kingdom and Belgium. Allan N. Maroli's co-authors include Royce W. Waltrip, Michael A. Becker, Herbert S. B. Baraf, Constantin Efthymiopoulos, Steven L. Bramer, William J. Huang, John S. Sundy, C. J. E. Niemegeers, Paul A. J. Janssen and Steven A. Hamburger and has published in prestigious journals such as JAMA, Cancer and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Allan N. Maroli

25 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment

2011 380 citations John S. Sundy, Herbert S. B. Baraf et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Allan N. Maroli United States	16	592	414	361	217	190	25	1.2k
Young Ok Kim South Korea	18	124 0.2×	168 0.4×	59 0.2×	327 1.5×	60 0.3×	97	1.3k
André Lussier Canada	14	146 0.2×	228 0.6×	410 1.1×	248 1.1×	232 1.2×	27	990
Yunfang Zhang China	19	311 0.5×	119 0.3×	37 0.1×	563 2.6×	67 0.4×	55	1.3k
Akira Itabashi Japan	24	70 0.1×	197 0.5×	137 0.4×	511 2.4×	59 0.3×	61	1.6k
W.H. Taylor United Kingdom	19	203 0.3×	144 0.3×	106 0.3×	258 1.2×	17 0.1×	67	1.1k
Georgia Antoniadi Greece	23	350 0.6×	149 0.4×	40 0.1×	313 1.4×	30 0.2×	77	1.4k
Simmons Rl United States	22	85 0.1×	660 1.6×	65 0.2×	142 0.7×	34 0.2×	127	1.7k
Vijaylaxmi Grey Canada	19	184 0.3×	122 0.3×	61 0.2×	242 1.1×	17 0.1×	43	1.3k
William W. Faloon United States	19	64 0.1×	308 0.7×	83 0.2×	158 0.7×	51 0.3×	49	1.1k
Dominic J. Nompleggi United States	14	73 0.1×	301 0.7×	41 0.1×	108 0.5×	40 0.2×	29	877

Countries citing papers authored by Allan N. Maroli

Since Specialization

Citations

This map shows the geographic impact of Allan N. Maroli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan N. Maroli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan N. Maroli more than expected).

Fields of papers citing papers by Allan N. Maroli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan N. Maroli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan N. Maroli. The network helps show where Allan N. Maroli may publish in the future.

Co-authorship network of co-authors of Allan N. Maroli

This figure shows the co-authorship network connecting the top 25 collaborators of Allan N. Maroli. A scholar is included among the top collaborators of Allan N. Maroli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan N. Maroli. Allan N. Maroli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sundy, John S., Herbert S. B. Baraf, Robert A. Yood, et al.. (2011). Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment. JAMA. 306(7). 711–711. 380 indexed citations breakdown →

Becker, Michael A., H. Ralph Schumacher, Katy Benjamin, et al.. (2009). Quality of Life and Disability in Patients with Treatment-Failure Gout. The Journal of Rheumatology. 36(5). 1041–1048. 135 indexed citations

Baraf, Herbert S. B., Alan K. Matsumoto, Allan N. Maroli, & Royce W. Waltrip. (2008). Resolution of gouty tophi after twelve weeks of pegloticase treatment. Arthritis & Rheumatism. 58(11). 3632–3634. 37 indexed citations

Sundy, John S., Michael A. Becker, Herbert S. B. Baraf, et al.. (2008). Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol–conjugated uricase) in patients with treatment‐failure gout: Results of a phase II randomized study. Arthritis & Rheumatism. 58(9). 2882–2891. 129 indexed citations

Yue, Corinne Seng, et al.. (2008). Population Pharmacokinetic and Pharmacodynamic Analysis of Pegloticase in Subjects With Hyperuricemia and Treatment‐Failure Gout. The Journal of Clinical Pharmacology. 48(6). 708–718. 19 indexed citations

Efthymiopoulos, Constantin, Steven L. Bramer, & Allan N. Maroli. (1997). Effect of Food and Gastric pH on the Bioavailability of Grepafloxacin. Clinical Pharmacokinetics. 33(Supplement 1). 18–24. 32 indexed citations

Efthymiopoulos, Constantin, Steven L. Bramer, & Allan N. Maroli. (1997). Effect of Age and Gender on the Pharmacokinetics of Grepafloxacin. Clinical Pharmacokinetics. 33(Supplement 1). 9–17. 17 indexed citations

Pettit, Rebecca, et al.. (1997). Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia. Journal of Antimicrobial Chemotherapy. 40(suppl 1). 73–81. 52 indexed citations

Efthymiopoulos, Constantin, et al.. (1997). Effect of Renal Impairment on the Pharmacokinetics of Grepafloxacin. Clinical Pharmacokinetics. 33(Supplement 1). 32–38. 18 indexed citations

10.

Maroli, Allan N., et al.. (1997). Efficacy and safety of grepafloxacin 600 mg daily for 10 days in patients with community-acquired pneumonia. Clinical Therapeutics. 19(5). 975–988. 20 indexed citations

11.

Efthymiopoulos, Constantin, Steven L. Bramer, & Allan N. Maroli. (1997). Pharmacokinetics of Grepafloxacin after Oral Administration of Single and Repeat Doses in Healthy Young Males. Clinical Pharmacokinetics. 33(Supplement 1). 1–8. 54 indexed citations

12.

Efthymiopoulos, Constantin, Steven L. Bramer, Allan N. Maroli, et al.. (1997). Grepafloxacin Pharmacokinetics in Individuals with Hepatic Dysfunction. Clinical Pharmacokinetics. 33(Supplement 1). 25–31. 11 indexed citations

13.

Efthymiopoulos, Constantin, et al.. (1997). Theophylline and Warfarin Interaction Studies with Grepafloxacin. Clinical Pharmacokinetics. 33(Supplement 1). 39–46. 26 indexed citations

14.

Hook, Edward W., William M. McCormack, David H. Martin, et al.. (1997). Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. The STD Study Group. Antimicrobial Agents and Chemotherapy. 41(8). 1843–1845. 12 indexed citations

15.

Galandiuk, Susan, George E. Block, Elliot Prager, et al.. (1994). Immunoscintigraphy with111 In-satumomab pendetide in patients with colorectal adenocarcinoma:. Diseases of the Colon & Rectum. 37(2). 129–137. 9 indexed citations

16.

Maroli, Allan N., et al.. (1987). The effect of food on ciramadol bioavailability in normal subjects. Biopharmaceutics & Drug Disposition. 8(3). 299–304. 2 indexed citations

17.

Colpaert, Françis C., Philippe De Witte, Allan N. Maroli, et al.. (1980). Self-administration of the analgesic suprofen in arthritic rats: Evidence of -induced arthritis as an experimental model of chronic pain. Life Sciences. 27(11). 921–928. 79 indexed citations

18.

Colpaert, F. C., C. J. E. Niemegeers, Paul A. J. Janssen, & Allan N. Maroli. (1980). The effects of prior fentanyl administration and of pain on fentanyl analgesia: tolerance to and enhancement of narcotic analgesia.. Journal of Pharmacology and Experimental Therapeutics. 213(2). 418–424. 58 indexed citations

19.

Stutz, Robert M., et al.. (1980). Facilitation of self-stimulation in rats by methadone. Pharmacology Biochemistry and Behavior. 13(6). 919–924. 4 indexed citations

20.

Maroli, Allan N., et al.. (1978). Morphine and self-stimulation: Evidence for action on a common neural substrate. Pharmacology Biochemistry and Behavior. 8(2). 119–123. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact